Dan L. Duncan Cancer Center Baylor College of Medicine Houston, Texas
The Cancer Center at the Baylor College of Medicine (BCM) was established in 2002. A generous grant from Dan L. Duncan in 2006 ensured its stability and growth. In 2007, the renamed Dan L. Duncan Cancer Center (DLDCC) received its NCI designation. The Center is located in Houston’s Texas Medical Center.
The Center focuses on cancer research, patient care, training, and education. The principal scientific partner of the Center is BCM, whose departments and programs in the basic sciences—particularly molecular and human genetics and molecular and cellular biology—enhance the work of DLDCC. An additional asset to the Center’s work is the Baylor Human Genome Sequencing Center which helps accelerate understanding of the genetic makeup of cancers, advancing the promise of personalized oncological care. DLDCC’s clinical partners include the Texas Children’s Hospital, the Michael E. DeBakey Veterans Affairs Medical Center, Ben Taub General Hospital of the Harris County Health District, and Baylor Clinic.
The Center’s research is organized around seven collaborative, multidisciplinary programs, including breast cancer, pediatric oncology, cancer biology, cancer cell and gene therapy, cancer prevention and population sciences, nuclear receptor biology, and molecular oncogenesis (carcinogenesis). There are three developing programs: prostate, gastrointestinal, and pancreatic cancer. Nearly 400 members are working at the Center, where there is an emphasis on programmatic interactions and collaborations between the basic scientists and clinicians, which enhance the translation of research findings to clinical care.
DLDCC is located in a large metropolitan area with a diverse population. Clinical partners such as the Harris County Health District provide opportunities for outreach to a wide range of diverse populations, including the medically underserved. To address the inequalities in care, the Center has created an Office of Outreach and Health Disparities to reduce cancer mortality within these populations. This office has created innovative, research-based techniques to educate underserved communities about cancer risk, such as a theater outreach program and the creation of “telenovelas.”
In addition, a variety of training programs enhance cancer research and education.
* This profile was provided by the Dan L. Duncan Cancer Center.